000 01592 a2200445 4500
005 20250514070414.0
264 0 _c20030620
008 200306s 0 0 eng d
022 _a0008-543X
024 7 _a10.1002/cncr.11395
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSpan, Paul N
245 0 0 _aMatrix metalloproteinase inhibitor reversion-inducing cysteine-rich protein with Kazal motifs: a prognostic marker for good clinical outcome in human breast carcinoma.
_h[electronic resource]
260 _bCancer
_cJun 2003
300 _a2710-5 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aBiomarkers, Tumor
_xanalysis
650 0 4 _aBreast Neoplasms
_xchemistry
650 0 4 _aDisease-Free Survival
650 0 4 _aFemale
650 0 4 _aGPI-Linked Proteins
650 0 4 _aGene Expression Regulation, Neoplastic
_xphysiology
650 0 4 _aHumans
650 0 4 _aMatrix Metalloproteinase Inhibitors
650 0 4 _aMatrix Metalloproteinases, Membrane-Associated
650 0 4 _aMembrane Glycoproteins
_xanalysis
650 0 4 _aMetalloendopeptidases
_xantagonists & inhibitors
650 0 4 _aMiddle Aged
650 0 4 _aPolymerase Chain Reaction
650 0 4 _aPrognosis
650 0 4 _aRNA, Messenger
_xanalysis
650 0 4 _aRegression Analysis
700 1 _aSweep, C G J
700 1 _aManders, Peggy
700 1 _aBeex, Louk V A M
700 1 _aLeppert, David
700 1 _aLindberg, Raija L P
773 0 _tCancer
_gvol. 97
_gno. 11
_gp. 2710-5
856 4 0 _uhttps://doi.org/10.1002/cncr.11395
_zAvailable from publisher's website
999 _c12553507
_d12553507